Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
View Patent ↗A cosmetic and/or pharmaceutical composition contains, as an active ingredient, at least one peptide from SEQ ID No1 to SEQ ID No8. The use of this peptide as an active ingredient for preparing compositions for inducing, increasing or restoring melanin synthesis in melanocytes of the skin or dermal papilla is also disclosed.
1. A cosmetic or pharmaceutical composition, comprising a peptide consisting of the amino acid sequence selected from the group consisting of:
(SEQ ID NO: 1)
Asn-Gly-Trp-Lys-Ile-Glu-Arg-Lys,
(SEQ ID NO: 2)
Asn-Gly-Trp-Arg-Val-Asp,
(SEQ ID NO: 3)
Trp-Arg-Leu-Asp-Arg-Lys,
(SEQ ID NO: 4)
Trp-Lys-Leu-Asp,
(SEQ ID NO: 5)
Trp-Arg-Val-Glu,
(SEQ ID NO: 6)
Trp-His-Leu-Glu,
(SEQ ID NO: 7)
Trp-Arg-Ala-Asp and
(SEQ ID NO: 8)
Trp-Lys-Ile-Asp,
in a physiologically acceptable medium.
2. The composition according to claim 1 , wherein said peptide consists of SEQ ID NO: 4.
3. The composition according to claim 1 , wherein said peptide consists of SEQ ID NO: 5.
4. The composition according to claim 1 , wherein at least one functional group of said peptide is protected by a protector group, the protector group being either an acylation or an acetylation of an amino-terminal end, or an amidation or an esterification of a carboxy-terminal end, or both.
5. The composition according to claim 1 , wherein said peptide is solubilized in advance in one or several cosmetically or pharmaceutically acceptable solvents.
6. The composition according to claim 1 , wherein said peptide is present in the composition in a concentration approximately between 0.0005 and 500 ppm.
7. The composition according to claim 1 , in a form adapted for topical application, the composition comprising a cosmetically or dermatologically acceptable medium.
8. The composition according to claim 1 , wherein said peptide is present in the composition as an active principle, alone or in association with at least one other active principle.
9. The composition according to claim 1 , further comprising at least one colorant exogenous to surface layers of the epidermis and/or at least one active pro-pigmenting principle different from said peptide, selected from substrates of tyrosinase, prostaglandins, cAMP activator compounds, and pigmenting plant extracts.
10. An isolated peptide consisting of the amino acid sequence selected from the group consisting of:
(SEQ ID NO: 1)
Asn-Gly-Trp-Lys-Ile-Glu-Arg-Lys,
(SEQ ID NO: 2)
Asn-Gly-Trp-Arg-Val-Asp,
(SEQ ID NO: 3)
Trp-Arg-Leu-Asp-Arg-Lys,
(SEQ ID NO: 4)
Trp-Lys-Leu-Asp,
(SEQ ID NO: 5)
Trp-Arg-Val-Glu,
(SEQ ID NO: 6)
Trp-His-Leu-Glu,
(SEQ ID NO: 7)
Trp-Arg-Ala-Asp, and
(SEQ ID NO: 8)
Trp-Lys-Ile-Asp.
11. A method of preparing a cosmetic composition or a pharmaceutical composition, comprising mixing a physiologically acceptable medium with at least one peptide according to claim 10 .
12. A method of stimulating natural pigmentation of skin, fur, or hair in a subject, comprising applying topically on an area to be treated of the subject a composition having an effective amount of at least one peptide according to claim 10 .
13. A cosmetic or pharmaceutical composition to prepare skin for sun exposure or to protect skin from solar radiation, comprising:
at least one active principle designed to prepare the skin for exposure to the sun or to protect the skin from solar radiation; and
at least one peptide according to claim 10 .
14. A composition to protect skin against any type of external aggression, comprising at least one peptide according to claim 10 .
15. A pharmaceutical composition to alleviate vitiligo, comprising:
a pharmaceutically acceptable medium; and
at least one peptide according to claim 10 .
16. A composition to inhibit or to treat whitening of fur and/or hair, comprising:
at least one compound that promotes pigmentation of the fur or hair; and
at least one peptide according to claim 10 .
17. A method of increasing synthesis of melanin by melanocytes and stimulating a process of melanin distribution in epidermis in a subject, comprising applying topically on an area to be treated of the subject an effective amount of at least one peptide according to claim 10 .
18. The composition according to claim 5 , wherein said one or several cosmetically or pharmaceutically acceptable solvents are selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, vaseline, vegetable oil, and any mixture of these solvents.
19. The composition according to claim 1 , wherein said peptide is present in the composition in a concentration between 0.01 ppm and 5 ppm.